Abstract
In the 1. part I would like to say something about how we have at our CBV (and associated institutions) solved the issue of drug development, practically from designing new molecules through the synthesis and testing to the use of new molecules in practice. Workshop would like to do interactive involvement in the debate, because some of you are doing similar research and as we encounter any problems, with which we could mutualy help.